Potential Bioactive Function of Microbial Metabolites as Inhibitors of Tyrosinase: A Systematic Review
Journal
International Journal of Molecular Sciences
ISSN
1661-6596
Publisher
MDPI AG
Date Issued
2026
Author(s)
Barcenas-Giraldo, Sofia
Baez-Leguizamon, Vanessa
Barbosa-Gonzalez, Laura
Leon-Rodriguez, Angelica
Diaz, Luis
Type
text::journal::journal article
Abstract
Tyrosinase (EC 1.14.18.1) is a binuclear copper enzyme responsible for the rate-limiting steps of melanogenesis, catalyzing the hydroxylation of L-tyrosine and oxidation of L-DOPA into o-quinones that polymerize melanin. Beyond its physiological role in pigmentation, tyrosinase is also implicated in food browning and oxidative stress–related disorders, making it a key target in cosmetic, food, and biomedical industries. This systematic review, conducted following PRISMA guidelines, aimed to identify and analyze microbial metabolites with tyrosinase inhibitory potential as sustainable alternatives to conventional inhibitors such as hydroquinone and kojic acid. Literature searches in Scopus and Web of Science (March 2025) yielded 156 records; after screening and applying inclusion criteria, 11 studies were retained for analysis. The inhibitors identified include indole derivatives, phenolic acids, peptides, and triterpenoids, mainly produced by fungi (e.g., Ganoderma lucidum, Trichoderma sp.), actinobacteria (Streptomyces, Massilia), and microalgae (Spirulina, Synechococcus). Reported IC50 values ranged from micromolar to milli-molar levels, with methyl lucidenate F (32.23 µM) and p-coumaric acid (52.71 mM). Mechanisms involved competitive and non-competitive inhibition, as well as gene-level regulation. However, methodological heterogeneity, the predominance of mushroom tyrosinase assays, and limited human enzyme validation constrain translational relevance. Computational modeling, site-directed mutagenesis, and molecular dynamics are proposed to overcome these limitations. Overall, microbial metabolites exhibit promising efficacy, stability, and biocompatibility, positioning them as emerging preclinical candidates for the development of safer and more sustainable tyrosinase inhibitors. ©The authors ©MDPI.
License
Acceso Abierto
How to cite
Barcenas-Giraldo, S., Baez-Leguizamon, V., Barbosa-Gonzalez, L., Leon-Rodriguez, A., Marrero-Ponce, Y., & Diaz, L. (2026). Potential Bioactive Function of Microbial Metabolites as Inhibitors of Tyrosinase: A Systematic Review. International Journal of Molecular Sciences, 27(2), 1016. https://doi.org/10.3390/ijms27021016